Synergistic effects of STK15 gene polymorphisms and endogenous estrogen exposure in the risk of breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 12, 2004, Pages 2065-2070

  Dai, Qi ^a   Cai, Qiu Yin ^a   Shu, Xiao Ou ^a   Ewart Toland, Amanda ^c   Wen, Wan Qing ^a   Balmain, Allan ^c   Gao, Yu Tang ^b   Zheng, Wei ^a,d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Medical Center East   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ISOLEUCINE; PHENYLALANINE; PROTEIN SERINE THREONINE KINASE;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD DONOR; BODY MASS; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CHILDBIRTH; CHINESE; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; ESTROGEN ACTIVITY; FEMALE; GENE; GENE FUNCTION; GENOTYPE; HUMAN; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MENSTRUATION; OBESITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; STK15 GENE;

ADULT; BODY MASS INDEX; BODY WEIGHT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; ESTROGENS; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS;

EID: 11144234946     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Tanaka T, Kimura M, Matsunaga K, Fukada D, Mori H, Okano Y. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res 1999;59:2041-4.
2. Bischoff JR, Plowman GD. The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis. Trends Cell Biol 1999;9:454-9.
3. Ewart-Toland A, Briassouli P, de Koning JP, et al. Identification of Stk6/STX15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Genet 2003;34:403-12.
4. Bischoff JR, Anderson L, Zhu Y, et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 1998;17:3052-65.
5. Zhou H, Kuang J, Zhong L, et al. Tumour amplified kinase STK15/ BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998;20:189-93.
6. Sen S, Zhou H, White RA. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 1997;14: 2195-200.
7. Miyoshi Y, Iwao K, Egawa C, Noguchi S. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int J Cancer 2001;92:370-3.
8. Kimura M, Kotani S, Hattori T, et al. Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, Aik, related to Aurora of Drosophila and yeast Ipl1. J Biol Chem 1997;272: 13766-71.
9. Iwabuchi H, Sakamoto M, Sakunaga H, et al. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res 1995; 55:6172-80.
10. Kallioniemi A, Kallioniemi OP, Piper J, et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci U S A 1994;91:2156-60.
11. Korn WM, Yasutake T, Kuo WL, et al. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer 1999;25:82-90.
12. Tanner MM, Grenman S, Koul A, et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 2000;6:1833-9.
13. Feigelson HS, Henderson BE. Estrogens and breast cancer. Carcinogenesis 1996;17:2279-84.
14. Yager JD. Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 2000;27:67-73.
15. Hamada M, Yakushijin Y, Ohtsuka M, Fujita S. Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkin's lymphoma. Br J Haematol 2003;121: 439-47.
16. Hodges LC, Cook JD, Lobenhofer EK, et al. Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells. Mol Cancer Res 2003;1:300-11.
17. Gao YT, Shu XO, Dai Q, et al. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer 2000;87:295-300.
18. Parkin DM, Whelen SL, Ferlay J, Raymond L. Cancer incidence in five continents. 7th ed. Lyon: IARC; 1997.
19. Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999;14:143-9.
20. Pritchard JK, Przeworski M. Linkage disequilibrium in humans: models and data. Am J Hum Genet 2001;69:1-14.
21. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995; 12:921-7.
22. Hodgson JG, Chin K, Collins C, Gray JW. Genome amplification of chromosome 20 in breast cancer. Breast Cancer Res Treat 2003;78: 337-45.
23. Muleris M, Almeida A, Gerbault-Seureau M, Malfoy B, Dutrillaux B. Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique. Genes Chromosomes Cancer 1994; 10:160-70.
24. Berry R, Schroeder JJ, French AJ, et al. Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet 2000;67: 82-91.
25. Collins C, Rommens JM, Kowbel D, et al. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci U S A 1998;95:8703-8.
26. Albertson DG, Ylstra B, Segraves R, et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 2000;25:144-6.
27. Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr 1987;45:277-82.
28. Pasquali R, Antenucci D, Melchionda N, et al. Sex hormones in obese premenopausal women and their relationships to body fat mass and distribution, B cell function and diet composition. J Endocrinol Invest 1987;10:345-50.
29. Seidell JC. Obesity, insulin resistance and diabetes-a worldwide epidemic. Br J Nutr 2000;83:S5-8.
30. Thorsen T, Lahooti H, Rasmussen M, Aakvaag A. Oestradiol treatment increases the sensitivity of MCF-7 cells for the growth stimulatory effect of IGF-I. J Steroid Biochem Mol Biol 1992;41:537-40.
31. Shu XO, Jin F, Dai Q, et al. Association of body size and fat distribution with risk of breast cancer among Chinese women. Int J Cancer 2001;94:449-55.
32. Krieger N. Exposure, susceptibility, and breast cancer risk: a hypothesis regarding exogenous carcinogens, breast tissue development, and social gradients, including black/white differences, in breast cancer incidence. Breast Cancer Res Treat 1989;13:205-23.
33. Russo J, Russo IH. Development pattern of human breast and susceptibility to carcinogenesis. Eur J Cancer Prev 1993;2:85-100.
34. Sen S, Zhou H, Zhang RD, et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 2002;94:1320-9.
35. Li D, Zhu J, Firozi PF, et al. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res 2003;9:991-7.
36. Sakakura C, Hagiwara A, Yasuoka R, et al. Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br J Cancer 2001;84: 824-31.
37. Tanner MM, Tirkkonen M, Kallioniemi A, et al. Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. Clin Cancer Res 1995;1:1455-61.
38. Parkin D, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
39. Balmain A. Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models. Cell 2002;108:145-52.